# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (NASDAQ:PRNB), a late-stage biopharmac...
Sanofi (NYSE: SNY) announced today that it intends to commence a tender offer (the "Offer") today to acquire all of the...
-SEC Filing
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24)
During Monday's morning session, 127 stocks hit new 52-week highs.
Upgrades
Stifel analyst Derek Archila downgrades Principia Biopharma (NASDAQ:PRNB) from Buy to Hold and lowers the price target from ...